Department of Dermatology, University of Lübeck, Germany.
J Pathol. 2011 Jun;224(2):234-44. doi: 10.1002/path.2857. Epub 2011 Mar 7.
Type VII collagen (COL7) is a major constituent of the cutaneous basement membrane. Loss of tolerance to COL7 leads to the blistering skin disease epidermolysis bullosa acquisita (EBA). Antibodies to COL7 have also been detected in patients with inflammatory bowel disease (IBD), yet reports on the expression of COL7 in the gut are controversial and a pathogenic relevance of anti-COL7 autoantibodies in IBD has not been demonstrated. We therefore characterized the expression patterns of COL7 in murine gastrointestinal organs and investigated if anti-COL7 antibodies induce an inflammatory response in the gut. COL7 expression was analysed on the mRNA and protein levels. Mice were injected with rabbit anti-murine COL7 IgG (passive EBA) or immunized with a fragment of murine COL7 (active EBA). COL7 was found to be expressed in buccal mucosa, oesophagus, stomach, small intestine, and colon. In addition to skin blistering, in both passive and active EBA, autoantibodies bound to the gastrointestinal basement membrane, fixed complement, and led to recruitment of leukocytes. Furthermore, blister formation was observed in the oesophagus (40%/38% of mice in passive/active model), stomach (40%/63%), small intestine (20%/13%), and colon (20%/13%). Compared to control animals, we found a significantly reduced body weight in diseased mice, suggesting that autoantibody-induced gastrointestinal inflammation is clinically relevant. Those observations may help us to understand the co-incidence of IBD with EBA, and vice versa: The inflammatory response in IBD might expose novel antigens (COL7), which leads to the formation of anti-COL7 antibodies. On the contrary, anti-COL7 antibody-induced gastrointestinal inflammation might pave the way for IBD pathogenesis. In summary, our results provide strong evidence that COL7 is expressed in different portions of the gut and that anti-COL7 antibodies induce distinct gastrointestinal tissue damage.
VII 型胶原(COL7)是皮肤基底膜的主要成分。对 COL7 的耐受性丧失会导致水疱性皮肤病获得性大疱性表皮松解症(EBA)。在炎症性肠病(IBD)患者中也检测到抗 COL7 抗体,但关于 COL7 在肠道中的表达的报告存在争议,并且抗 COL7 自身抗体在 IBD 中的致病相关性尚未得到证实。因此,我们在鼠胃肠道器官中对 COL7 的表达模式进行了特征描述,并研究了抗 COL7 抗体是否会在肠道中引起炎症反应。分析了 COL7 在 mRNA 和蛋白质水平上的表达。用兔抗鼠 COL7 IgG(被动 EBA)或鼠 COL7 片段(主动 EBA)免疫小鼠。发现 COL7 在口腔黏膜、食管、胃、小肠和结肠中有表达。除了皮肤水疱外,在被动和主动 EBA 中,自身抗体与胃肠道基底膜结合,固定补体,并导致白细胞募集。此外,还观察到食管(被动/主动模型中 40%/38%的小鼠)、胃(40%/63%)、小肠(20%/13%)和结肠(20%/13%)形成水疱。与对照动物相比,患病小鼠的体重明显减轻,这表明自身抗体诱导的胃肠道炎症具有临床相关性。这些观察结果可能有助于我们理解 IBD 与 EBA 的同时发生,反之亦然:IBD 中的炎症反应可能会暴露新的抗原(COL7),从而导致抗 COL7 抗体的形成。相反,抗 COL7 抗体诱导的胃肠道炎症可能为 IBD 的发病机制铺平道路。总之,我们的结果提供了强有力的证据,证明 COL7 在肠道的不同部位表达,并且抗 COL7 抗体诱导明显的胃肠道组织损伤。